On September 15, 2026, Lili Huang's long position ratio in GENSCRIPT BIO (01548) was passively diluted following the company's placement of 77,126,000 new shares under the general mandate.
Prior to the dilution, Huang's long position was 801.15 million shares, representing 36.36%; following the placing, the holding remained unchanged at 801.15 million shares, but the long position ratio fell to 35.13%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments